We found a differential internalization of these mAb in B cells from patients with SLE, with rapid internalization of anti‐CD22 mAb that was unaffected by FcγRIIb and with variable internalization and regulation of anti‐CD19 mAb by FcγRIIb. This evidence concerns the gene CD22 and systemic lupus erythematosus.